Pharmacovigilance and spontaneous adverse drug reaction reporting
Perspectives in Clinical Research · 2022-10 · 13 (4) · 177-179
DOI: 10.4103/picr.picr_169_22 ↗Kurz gefasst
Editorial in der Zeitschrift Perspectives in Clinical Research, 2022-10. Verfasst von Mira Desai. Beteiligte Einrichtung: Department of Pharmacology, Nootan Medical College and Research Centre, Visnagar, Gujarat, India. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Although the strategies in controlled clinical trials are to identify the safety and the risk associated with the use of medicines, it does not reflect the way the medicines are used in real life practice. Therefore, the postmarketing safety monitoring of medicines through pharmacovigilance (PV) system is essential and continues throughout the marketed life of medicines. The recent pandemic has been a good example to highlight the importance of the safety monitoring of medicines and vaccines during public health emergency. The accelerated approval of “repurposed” medicines for COVID-19 and “compassionate use” of bedaquiline for drug-resistant TB has proved the crucial role of PV to support regulatory decisions and ensure patients’ safety.
Autor:innen und Institutionen
- Department of Pharmacology, Nootan Medical College and Research Centre, Visnagar, Gujarat, India.
Zitieren
APA
Desai, M. (2022). Pharmacovigilance and spontaneous adverse drug reaction reporting. Perspectives in Clinical Research, 13(4), 177-179. https://doi.org/10.4103/picr.picr_169_22
Vancouver
Desai M. Pharmacovigilance and spontaneous adverse drug reaction reporting. Perspectives in Clinical Research. 2022;13(4):177-179. doi:10.4103/picr.picr_169_22
BibTeX
@article{Desai2022,
author = {Desai, Mira},
title = {Pharmacovigilance and spontaneous adverse drug reaction reporting},
journal = {Perspectives in Clinical Research},
year = {2022},
volume = {13},
number = {4},
pages = {177--179},
doi = {10.4103/picr.picr_169_22}
}
EUVIMED